Ulrike Kuckelkorn Selected Research

Ulrike Kuckelkorn Research Topics

Disease

10	Neoplasms (Cancer) 10/2019 - 01/2002
4	Melanoma (Melanoma, Malignant) 12/2015 - 08/2006
4	Infections 01/2012 - 11/2006
3	Multiple Myeloma 10/2015 - 03/2007
3	Inflammation (Inflammations) 10/2014 - 01/2010
2	Rheumatoid Arthritis 01/2020 - 10/2002
2	Autoimmune Diseases (Autoimmune Disease) 10/2019 - 10/2002
2	Brain Injuries (Brain Injury) 11/2016 - 11/2012
2	Stroke (Strokes) 11/2016 - 11/2012
2	Sjogren's Syndrome (Sjogren Syndrome) 05/2013 - 12/2009
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2010 - 01/2010
1	Brain Edema (Cerebral Edema) 11/2016
1	Brain Ischemia (Cerebral Ischemia) 11/2016
1	Infarction (Infarctions) 11/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2016
1	Encephalitis (Encephalitis, Rasmussen) 11/2016
1	Leukocytosis (Pleocytosis) 11/2016
1	Hypoxia (Hypoxemia) 10/2015
1	Hyperlipidemias (Hyperlipidemia) 10/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2014
1	Body Weight (Weight, Body) 10/2014
1	Chronic Disease (Chronic Diseases) 09/2011
1	Heart Diseases (Heart Disease) 09/2011
1	Communicable Diseases (Infectious Diseases) 09/2011
1	Heart Failure 01/2010
1	Myocarditis (Carditis) 08/2009
1	Bone Diseases (Bone Disease) 02/2009
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2008
1	Reperfusion Injury 12/2007
1	Paraproteinemias (Monoclonal Gammopathy) 03/2007
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 07/2004
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2004
1	Disease Progression 07/2004
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2002
1	Myasthenia Gravis 10/2002

Drug/Important Bio-Agent (IBA)

19	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 10/2002
9	Proteasome InhibitorsIBA 11/2016 - 08/2006
5	BSc2118IBA 11/2016 - 08/2010
4	AntigensIBA 10/2019 - 10/2002
4	EpitopesIBA 12/2015 - 01/2002
4	Bortezomib (Velcade)FDA Link 10/2015 - 02/2008
3	Peptides (Polypeptides)IBA 12/2015 - 04/2007
2	Protein Isoforms (Isoforms)IBA 10/2019 - 09/2011
2	UbiquitinIBA 11/2016 - 08/2010
2	Proteins (Proteins, Gene)FDA Link 12/2015 - 01/2010
2	LigandsIBA 11/2014 - 01/2008
2	InterferonsIBA 09/2011 - 08/2009
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 08/2009 - 11/2006
1	Abatacept (Orencia)FDA Link 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	AminopeptidasesIBA 12/2015
1	MART-1 AntigenIBA 12/2015
1	Differentiation AntigensIBA 12/2015
1	oxidized low density lipoproteinIBA 10/2015
1	carfilzomibIBA 11/2014
1	Gentian Violet (Violet, Crystal)FDA Link 10/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2012
1	Saline SolutionIBA 11/2012
1	CytokinesIBA 09/2011
1	Histocompatibility Antigens Class IIBA 09/2011
1	Capsid Proteins (Capsid Protein)IBA 08/2009
1	Interferon Type IIBA 08/2009
1	CurcuminIBA 02/2009
1	Histone Deacetylase InhibitorsIBA 02/2008
1	Pioglitazone (Actos)FDA Link 01/2008
1	PPAR gammaIBA 01/2008
1	Cytostatic AgentsIBA 01/2008
1	Cyclin D1IBA 01/2008
1	Heme Oxygenase-1IBA 12/2007
1	HLA-A*02:01 antigenIBA 04/2007
1	EnzymesIBA 03/2007
1	CalpainIBA 08/2006
1	Cisplatin (Platino)FDA LinkGeneric 08/2006
1	AntibodiesIBA 07/2004
1	AutoantibodiesIBA 07/2004
1	Thyroglobulin FDA Link 07/2004
1	Interferon-gamma (Interferon, gamma)IBA 01/2002

Therapy/Procedure

2	Immunotherapy 12/2015 - 01/2002
1	Thrombolytic Therapy 11/2012
1	Injections 11/2012
1	Therapeutics 11/2012
1	Drug Therapy (Chemotherapy) 08/2006
1	Thymectomy 10/2002